Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Francisco, California 94143


This is a prospective pilot study that will document the clinical experience of 30 patients with unresectable hepatocellular carcinoma undergoing liver-directed therapy with Yttrium-90 glass microspheres (TheraSphere®).


Inclusion Criteria: - Diagnosis of hepatocellular carcinoma with liver-dominant disease. Diagnosis may be made by histo- or cyto-pathology, or by clinical and imaging criteria. - The cancer is unresectable. - All patients must be off all chemotherapeutic regimens for 30 days prior to and 30 days after TheraSphere treatment. - Eastern Cooperative Oncology Group (ECOG) performance status of 0-2. - Age 18 years or older. - Able to understand informed consent. Exclusion Criteria: - Evidence of potential delivery of greater than 16.5 mCi (30 Gy absorbed dose) of radiation to the lungs on either: - single TheraSphere administration; or - cumulative delivery of radiation to the lungs greater than 50 Gy over multiple treatments. - Evidence of any detectable Tc-99m macroaggregated albumin flow to the stomach or duodenum, after application of established angiographic techniques to stop such flow. - Previous radiation therapy to the lungs and/or to the upper abdomen - Pregnancy - Symptomatic lung disease. - Significant extrahepatic disease representing an imminent life-threatening outcome. - Active uncontrolled infection - Any pre-treatment laboratory findings within 30 days of treatment demonstrating: - Aspartate or alanine aminotransferase level greater than 5 times upper normal limit. - Serum bilirubin greater than 2 mg/dl - Infiltrative tumor on imaging - Tumor volume greater than 70% of liver volume - Tumor volume greater than 50% of liver volume and serum albumin level less than 3 mg/dL



Primary Contact:

Principal Investigator
Nicholas Fidelman, MD
University of California, San Francisco

Backup Contact:


Location Contact:

San Francisco, California 94143
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.